BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34684743)

  • 1. In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of
    Vieira TF; Martins FG; Moreira JP; Barbosa T; Sousa SF
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions.
    Hanwarinroj C; Thongdee P; Sukchit D; Taveepanich S; Kamsri P; Punkvang A; Ketrat S; Saparpakorn P; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
    J Mol Graph Model; 2022 Sep; 115():108231. PubMed ID: 35667143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity.
    Xu J; Wang JX; Zhou JM; Xu CL; Huang B; Xing Y; Wang B; Luo R; Wang YC; You XF; Lu Y; Yu LY
    Sci Rep; 2017 Jul; 7(1):5093. PubMed ID: 28698545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.
    Wlodarchak N; Teachout N; Beczkiewicz J; Procknow R; Schaenzer AJ; Satyshur K; Pavelka M; Zuercher W; Drewry D; Sauer JD; Striker R
    Mol Pharm; 2018 Nov; 15(11):5410-5426. PubMed ID: 30285456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity and Reactivity of
    Burastero O; Cabrera M; Lopez ED; Defelipe LA; Arcon JP; Durán R; Marti MA; Turjanski AG
    J Chem Inf Model; 2022 Apr; 62(7):1723-1733. PubMed ID: 35319884
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
    Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
    Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis Ser/Thr protein kinase B mediates an oxygen-dependent replication switch.
    Ortega C; Liao R; Anderson LN; Rustad T; Ollodart AR; Wright AT; Sherman DR; Grundner C
    PLoS Biol; 2014 Jan; 12(1):e1001746. PubMed ID: 24409094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.
    Singh N; Tiwari S; Srivastava KK; Siddiqi MI
    J Chem Inf Model; 2015 Jun; 55(6):1120-9. PubMed ID: 25965448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Highly Disparate Dual Inhibitory Mechanisms of Novel Quinazoline Derivatives against
    Olotu FA; Soliman ME
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947886
    [No Abstract]   [Full Text] [Related]  

  • 10. Virtual Screening Identifies Novel and Potent Inhibitors of
    Thongdee P; Hanwarinroj C; Pakamwong B; Kamsri P; Punkvang A; Leanpolchareanchai J; Ketrat S; Saparpakorn P; Hannongbua S; Ariyachaokun K; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Mukamolova GV; Blood RA; Takebayashi Y; Spencer J; Mulholland AJ; Pungpo P
    J Chem Inf Model; 2022 Dec; 62(24):6508-6518. PubMed ID: 35994014
    [No Abstract]   [Full Text] [Related]  

  • 11. Multisystem Analysis of
    Carette X; Platig J; Young DC; Helmel M; Young AT; Wang Z; Potluri LP; Moody CS; Zeng J; Prisic S; Paulson JN; Muntel J; Madduri AVR; Velarde J; Mayfield JA; Locher C; Wang T; Quackenbush J; Rhee KY; Moody DB; Steen H; Husson RN
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosis.
    Brindha S; Vincent S; Velmurugan D; Ananthakrishnan D; Sundaramurthi JC; Gnanadoss JJ
    Med Hypotheses; 2017 Jun; 103():39-45. PubMed ID: 28571806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents.
    Lougheed KE; Osborne SA; Saxty B; Whalley D; Chapman T; Bouloc N; Chugh J; Nott TJ; Patel D; Spivey VL; Kettleborough CA; Bryans JS; Taylor DL; Smerdon SJ; Buxton RS
    Tuberculosis (Edinb); 2011 Jul; 91(4):277-86. PubMed ID: 21482481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting PknB, an eukaryotic-like serine/threonine protein kinase of Mycobacterium tuberculosis with phytomolecules.
    Appunni S; Rajisha PM; Rubens M; Chandana S; Singh HN; Swarup V
    Comput Biol Chem; 2017 Apr; 67():200-204. PubMed ID: 28131886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
    Gupta A; Pal SK; Pandey D; Fakir NA; Rathod S; Sinha D; SivaKumar S; Sinha P; Periera M; Balgam S; Sekar G; UmaDevi KR; Anupurba S; Nema V
    Ann Clin Microbiol Antimicrob; 2017 Aug; 16(1):56. PubMed ID: 28821299
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Eduardo Sanabria-Chanaga E; Betancourt-Conde I; Hernández-Campos A; Téllez-Valencia A; Castillo R
    J Biomol Struct Dyn; 2019 Oct; 37(16):4301-4311. PubMed ID: 30477412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of the Mycobacterium tuberculosis serine/threonine protein kinase PknB.
    Av-Gay Y; Jamil S; Drews SJ
    Infect Immun; 1999 Nov; 67(11):5676-82. PubMed ID: 10531215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactome analysis and design of inhibitors against selected protein targets of Ser/Thr protein kinase (STPK) signaling pathways in Mycobacterium tuberculosis H37Rv.
    Gurung AB; Mylliemngap BJ; Bhattacharjee A; Ali MA; Al-Hemaid FM
    Genet Mol Res; 2015 Sep; 14(3):10390-403. PubMed ID: 26345980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.